Introduction: Retinoic acid is a metabolite of Vitamin A (retinol) has been reported to activate PI3K/Akt pathway and up regulate NO synthesis that has a beneficial effect in the endothelial cell. Thus, the present study was designed to investigate the effect of retinoic acid in HHcy induced vascular dysfunction.
Objective: This study evaluates the protective effect of retinoic acid on L-methionine-induced Hyperhomocysteinemia (HHcy) in rats.
Materials and methods: Wistar rats were randomly divided into seven groups as normal control, L-methionine, HHcy+Retinoic acid (2.5 mg/kg/d), HHcy+RA (5 mg/kg/d), HHcy+RA (5 mg/kg/d) + BEZ235 (4 mg/kg/d), HHcy+RA (5 mg/kg/d)+L-NAME (10 mg/kg/d), HHcy+Lisinopril (1 mg/ kg./d). HHcy was induced by oral administration of L-methionine (1.7 g/kg) for 28 days. From the 21st day of study retinoic acid (2, 2.5 mg/kg), BEZ235, L-NAME, Lisinopril was administered to L-methionine-treated rats. Different biomarkers of HHcy in serumand vascular reactivity were evaluated.
Results: L-methionine administration, vascular endothelium dysfunction was assessed in terms of attenuation of acetylcholine-inducedendothelium-dependent relaxation (Isolated aortic ring preparation), a decrease in serum nitrite level, mRNA expression of eNOS (rtPCR). Administration of retinoic acid (2.5 mg/kg/d and 5 mg/kg/d, 21st to 28th day) significantly improved acetylcholine-induced endothelium-dependent relaxation, serum nitrate/nitrite level, mRNA expression of eNOS. This ameliorative effect of retinoic acid was blocked by BEZ235 (a PI3K /mTOR dual inhibitor) and L-NAME (NOS inhibitor).
Conclusion: Retinoic acid attenuates hyperhomocysteinemia induced vascular endothelium dysfunction in Wistar rats by activation of PI3K/mTOR and eNOS pathway.
Select your language of interest to view the total content in your interested language
Annals of Medical and Health Sciences Research received 15898 citations as per google scholar report